{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:21:19Z","timestamp":1773523279901,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Osimertinib-induced severe lymphocytopenia can create a profound immunodeficiency state, facilitating opportunistic infections and progressive fibrotic lung disease. A 75-year-old female with EGFR-mutant NSCLC developed respiratory failure with diffuse ground-glass opacities and profound lymphocytopenia (ALC 0.48\u00d710\n                    <jats:sup>9<\/jats:sup>\n                    \/L). Overreliance on BAL-NGS detection of Mycobacterium avium complex delayed diagnosis of cytomegalovirus pneumonia. Guideline-discordant erlotinib rechallenge accelerated lymphocyte depletion, culminating in high-grade CMV viremia with CD4\n                    <jats:sup>+<\/jats:sup>\n                    lymphocytopenia (0.16\u00d710\n                    <jats:sup>9<\/jats:sup>\n                    \/L) and irreversible pulmonary fibrosis despite ganciclovir-induced virologic clearance. This case demonstrates an immune-fibrotic axis wherein TKI-induced lymphocytopenia enables CMV pneumonitis and fibrotic remodeling. Lymphocytopenia in this setting mandates urgent viral exclusion before attributing injury to drug toxicity and precludes TKI rechallenge during active infection or severe immunosuppression. BAL-NGS requires rigorous clinicoradiologic correlation.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1702074","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:20:23Z","timestamp":1765948823000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Lymphocyte dynamics as the central mediator in osimertinib-induced CD4+ T-cell depletion, fulminant cytomegalovirus pneumonitis, and progressive pulmonary fibrosis: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Liya","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2022.04.005","article-title":"Osimertinib-induced lymphocytopenia and pneumocystis jirovecii pneumonia","volume":"28","author":"Takechi","year":"2022","journal-title":"Pulmonology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy295","article-title":"Absolute lymphocyte count: A predictor of recurrent cytomegalovirus disease in solid organ transplant recipients","volume":"67","author":"Gardiner","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.37201\/req\/s03.16.2022","article-title":"Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies","author":"Garc\u00eda-Bustos","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte","year":"2022","journal-title":"ESMO Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13244-024-01771-z","article-title":"The radiologist\u2019s role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review","volume":"15","author":"Dinkel","year":"2024","journal-title":"Insights Imaging"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000530844","article-title":"Mycobacterium avium Complex Infections: Detailed Phenotypic and Functional Immunological Work-Up Is Required despite Genetic Analyses","volume":"184","author":"Kratzer","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-1105-1","article-title":"Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature","volume":"46","author":"Knoll","year":"2018","journal-title":"Infection"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-022-02118-8","article-title":"Correction to: Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)","volume":"27","author":"Tsubata","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.17627","article-title":"Blood concentrations of osimertinib and its active metabolites: impact on treatment efficacy and safety","volume":"45","author":"Okuno","year":"2025","journal-title":"Anticancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou029","article-title":"A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma","volume":"16","author":"Clarke","year":"2014","journal-title":"Neuro Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7150\/thno.54824","article-title":"Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2010.12.011","article-title":"Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf\/ERK cascade and Akt signaling pathway","volume":"251","author":"Luo","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199907083410203","article-title":"Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group","volume":"341","author":"Kovacs","year":"1999","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"eaar8356","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-1-205","article-title":"Transforming growth factor beta production during rat cytomegalovirus infection","volume":"78","author":"Haagmans","year":"1997","journal-title":"J Gen Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-77349-8_12","article-title":"Human cytomegalovirus modulation of signal transduction","volume":"325","author":"Yurochko","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5366","article-title":"Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-\u03b21","volume":"14","author":"Li","year":"2016","journal-title":"Mol Med Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","article-title":"Neutrophil extracellular traps promote differentiation and function of fibroblasts","volume":"233","author":"Chrysanthopoulou","year":"2014","journal-title":"J Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-023-00329-y","article-title":"Neutrophil extracellular traps and pulmonary fibrosis: an update","volume":"20","author":"Yan","year":"2023","journal-title":"J Inflammation (Lond)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-683OC","article-title":"Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis","volume":"176","author":"Tzouvelekis","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30487","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0056","article-title":"Prevention and treatment of cancer-related infections, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Baden","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/s41598-019-38618-3","article-title":"Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw539","article-title":"The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma","volume":"63","author":"Del Castillo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.652665","article-title":"Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection","volume":"44","author":"Kim","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu","year":"2019","journal-title":"Annu Rev Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1702074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:20:24Z","timestamp":1765948824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1702074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2025.1702074"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1702074","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1702074"}}